GlobeNewswire
-
Clene to Present at Upcoming May Conferences
05/05/2026 -
Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026
05/05/2026 -
Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results
05/05/2026 -
Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025
05/05/2026 -
Geron Plans to Present at Upcoming Investor Conferences
05/05/2026 -
Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates
05/05/2026 -
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
05/05/2026 -
FEATOL Introduces Back Brace Support Belt for Everyday Lower Back Support
05/05/2026 -
MindBio Develops Cross-Language AI Speech Analytics Capability for Intoxication Detection Patent applications filed in 15 world firsts using Voice and AI
05/05/2026 -
Alpha Tau Announces Upcoming Podium Presentation at the AHNS 12th International Conference on Head and Neck Cancer Showcasing Study Results of Alpha DaRT® Head and Neck Cancer Combination with Pembrolizumab
05/05/2026 -
SK pharmteco Achieves SBTi Validation for 2040 Net-Zero Science-Based Targets
05/05/2026 -
Health Canada Authorizes North America’s First Hepatitis B Rapid Test, bioLytical’s iStatis Hepatitis B Surface Antigen Test
05/05/2026 -
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
05/05/2026 -
MAPS & State of Colorado Partner to Deliver Free Harm Reduction Training for First Responders
05/05/2026 -
Biosphere Awarded $9 Million U.S. Army Contract to Develop On-Demand Nutrition Production System for Warfighters
05/05/2026 -
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026
05/05/2026 -
Bicycle Health Expands Leadership Team to Increase Access to Evidence-Based Opioid Use Disorder Care
05/05/2026 -
Precision Optics Announces Receipt of $3.5 Million Follow-On Production Order for Single-Use Ophthalmic Program
05/05/2026 -
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
05/05/2026
Pages